Compare Organon & Co. Common Stock (OGN) vs TotalEnergies SE (TTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs TotalEnergies SE — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while TotalEnergies SE trades at $90 (market cap $196.57B). The key difference: TotalEnergies SE is far larger — about 54.3× Organon & Co. Common Stock's market cap, and TotalEnergies SE pays the higher dividend (4.76%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and TotalEnergies SE for 91 Days on average.
| OGN | TTE | |
|---|---|---|
Market Cap | $3.62B | $196.57B |
Volume | 2,892,999 | 2,606,285 |
Sector | Health | Energy |
52-Week High | $13.81 | $93.60 |
52-Week Low | $5.70 | $60.44 |
Typical Hold Time | 0 Days | 91 Days |
Enterprise Value | $11.04B | $227.56B |
Dividend Yield | 0.58% | 4.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
TotalEnergies (TTE) trades at $88.95, up 0.66% today, with a bullish technical signal and strong analyst support. The stock shows robust fundamentals with a P/E of 11.13 and ROE of 14.56%, though revenue has declined from $263.3B in 2022 to $182.3B in 2025. Recent news highlights a $10B investment in Argentina and a $2.5B Q4 buyback increase, signaling aggressive growth plans.
Outlook remains positive with a consensus price target of $95.33, but risks include volatile oil prices and execution of expansion strategies. The company's focus on LNG and power diversification, coupled with a 5% dividend growth target by 2030, offers a balanced opportunity for value investors seeking energy exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →
